Search bioRxiv⌕ Search

Biology subjects

Antipova, N. V.

Publications and source records attributed to Antipova, N. V..

3 recordsLinked to original sources

NONO as a Sensor of Intracellular Oxidation: Relevance to Neuroblastoma Cell Death

Neuroblastoma, a transcriptionally driven pediatric malignancy, exhibits a remarkable clinical and biological heterogeneity. Two major subtypes, the adrenergic and mesenchymal, are differentially governed by a subset of transcription factors that comprise the core regulatory circuit (CRC). The former subtype is often associated with MYCN amplification and is particularly aggressive and therapy-resistant, underscoring the need for novel targets. Here, we identify the multifunctional non-POU domain-containing octamer-binding (NONO) protein as a guardian of individual CRC genes, thereby contributing to survival of neuroblastoma cells with different MYCN copy numbers. Intracellular oxidation in response to auranofin, an inhibitor of thioredoxin reductase 1, rapidly down-regulated the amounts of NONO mRNA and protein in MYCN-amplified Kelly cell line. Conversely, NONO knockdown with RNA interference (siNONO) also triggered intracellular oxidation. These effects were less pronounced in the SK-N-AS cell line carrying a single MYCN copy, as well as in non-malignant HS5 fibroblasts. In Kelly cells, siNONO attenuated auranofin-induced activation of CRC genes HAND2 and PHOX2B. In line with preferential effects on NONO abundance, the Kelly cells were more sensitive than single MYCN copy counterparts to combinations of a sublethal concentration of auranofin with siNONO. Importantly, MYCN-amplified cells demonstrated a significantly suppressed clonogenic survival 14 days after transient exposure to these combinations compared with each agent alone; HS5 fibroblasts were largely spared. Our findings 1) establish NONO as a redox sensor, a non-trivial role for transcriptional proteins, and 2) justify the strategy of therapeutic targeting of MYCN-amplified tumors vulnerable to oxidative stress. Key pointsO_LINONO, a master regulator of the core regulatory circuit (CRC) in MYCN-amplified neuroblastoma, is rapidly down-regulated by auranofin-induced intracellular oxidation. C_LIO_LINONO knockdown synergizes with auranofin in triggering individual CRC gene deregulation and lethal oxidative stress preferentially in MYCN-amplified cells. C_LI

cancer biology↗

Patient-derived glioblastoma neurosphere cultures differentially express nicotinic acetylcholine receptors depending on ambient choline

Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer with a poor prognosis. GBM cells, developing in the environment of neural tissue, often exploit neurotransmitters and their receptors to promote their growth and invasion. Nicotinic acetylcholine receptors (nAChRs) play a crucial role in the central nervous system signal transmission, are widely represented in the brain, the GBM cells expressing several subtypes of nAChRs which are suggested to transmit signals from neurons, thus promoting tumor invasion and growth. Functional 1*, 7 and 9 nAChRs are demonstrated on several patient-derived GBM neurosphere cultures and U87MG cell line using neurotoxins and fluorescent calcium assay. Selective 1*, 7 and 9 nAChR antagonists stimulated cell growth in presence of nicotinic agonists. Choline, normally present in blood, is capable of activating 1*, 7 and 9 nAChR subtypes, mediates the antagonists influence on cell proliferation. Several cultivating conditions have been shown to directly change sensitivity of primary GBM lines to nAChR ligands. Thus, results of in vitro testing of nAChR ligands on GBM lines should be interpreted and reviewed in cell culture conditions-aware manner.

molecular biology↗

Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2

In 2020 the world faced the pandemic of COVID-19 - severe acute respiratory syndrome caused by a new type of coronavirus named SARS-CoV-2. To stop the spread of the disease, it is crucial to create molecular tools allowing to investigate, diagnose and treat COVID-19. One of such tools are monoclonal antibodies (mAbs). In this study we describe the development of hybridoma cells that can produce mouse mAbs against receptor binding domain of SARS-CoV-2 spike (S) protein. These mAbs are able to specifically detect native and denaturized S protein in all tested applications including immunoblotting, immunofluorescence staining and enzyme-linked immunosorbent assay. In addition, we showed that the obtained mAbs decreased infection rate of human cells by SARS-CoV-2 pseudovirus particles in in vitro experiments. Finally, we determined the amino acid sequence of light and heavy chains of the mAbs. This information will allow to use the corresponding peptides to establish genetically engineered therapeutic antibodies. To date multiple mAbs against SARS-CoV-2 proteins have been established, however due to the restrictions caused by pandemic, it is imperative to have a local source of the antibodies suitable for researches and diagnostics of COVID-19. Moreover, as each mAb has a unique binding sequence, bigger sets of various antibodies will allow to detect SARS-CoV-2 proteins even if the virus acquires novel mutations.

biochemistry↗